India Pharma Outlook Team | Thursday, 16 October 2025
Fortis Hospital, Mulund, has inaugurated its Fortis Cancer Institute and Institute of GastroSciences, marking a significant milestone in its mission to deliver comprehensive, patient-first healthcare. The ceremony was graced by acclaimed actor and cancer survivor Mahima Chaudhry, whose presence inspired patients, caregivers, and the community.
The new wing integrates cutting-edge diagnostic and treatment technologies with an empathetic care environment, reflecting Fortis Mulund’s vision of blending clinical excellence with holistic healing. Dr. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, stated, “This launch underscores our commitment to building centres of excellence that combine innovation, integration, and compassion.”
The Fortis Cancer Institute offers multidisciplinary oncology services, including medical, surgical, and radiation oncology, along with advanced genetic and molecular therapies. Personalized treatments such as immunotherapy, targeted therapy, and robotic surgeries are complemented by psycho-oncology, nutrition counselling, Yoga, and survivorship programs under the leadership of Dr. Boman Dhabhar.
Also Read: Neeraj Garg Appointed CEO of Aragen Discovery Solutions
The Institute of GastroSciences, led by Dr. Vipulroy Rathod, provides comprehensive care for gastrointestinal, liver, and pancreatic disorders, utilizing advanced endoscopic and interventional techniques including ERCP, EUS, capsule endoscopy, and therapeutic resections.
Dr. S Narayani, business head, Fortis Hospitals Maharashtra, added, “By integrating oncology and gastroenterology under one roof, we ensure continuum-based, patient-centered care.” Mahima Chaudhry highlighted the importance of early detection, compassionate care, and support in the healing journey.
The new facility positions Fortis Mulund as a hub of innovation, empathy, and clinical excellence, reinforcing Fortis Healthcare’s leadership in specialty care across India.
